Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

scientific article published on May 1988

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1056/NEJM198805053181805
P698PubMed publication ID3283548

P2093author name stringPeto R
Collins R
Yusuf S
Scrimgeour A
P433issue18
P407language of work or nameEnglishQ1860
P921main subjectthrombosisQ261327
P304page(s)1162-1173
P577publication date1988-05-01
P1433published inThe New England Journal of MedicineQ582728
P1476titleReduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery
P478volume318

Reverse relations

cites work (P2860)
Q34707410A 56-year-old woman with early acute pulmonary emboli following pelvic reconstructive surgery
Q37205453A National Analysis of Complications Following Total Hip Replacement in Patients With Chronic Obstructive Pulmonary Disease
Q37876398A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.
Q33823987A clinical decision support system for venous thromboembolism prophylaxis at a general hospital in a middle-income country
Q33489807A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
Q53925915A geriatric-anesthesiologic program to reduce acute confusional states in elderly patients treated for femoral neck fractures.
Q46163394A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).
Q38268898A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal
Q38065716Acute pulmonary embolectomy
Q35667911Acute pulmonary embolism after pneumonectomy
Q44877496Advances in bioresponsive closed-loop drug delivery systems
Q35704525Anticoagulant drugs in the elderly: the risks usually outweight the benefits
Q35704478Anticoagulant drugs in the elderly: valuable in selected patients
Q24187310Anticoagulants for acute ischaemic stroke
Q24240765Anticoagulants for acute ischaemic stroke
Q24246662Anticoagulants for acute ischaemic stroke
Q68436855Anticoagulants in the prevention of venous thromboembolism
Q43942831Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin
Q40647947Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration
Q40647941Antiplatelet treatment for thromboprophylaxis: a step forward or backwards?
Q38665558Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism
Q35752541Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Q33732426Archie Cochrane's challenge: can periodically updated reviews of all randomised controlled trials relevant to neurology and neurosurgery be produced?
Q38572083Are Higher Hospital Venous Thromboembolism Rates an Indicator of Better Quality?: Evaluation of the Validity of a Hospital Quality Measure
Q35174317Attitudes to the use of prophylaxis for thrombo-embolism in neurosurgical patients
Q41117809Audit of attitudes to and use of postoperative thromboembolic prophylaxis in a regional health authority
Q41247295Bemiparin for thromboprophylaxis after benign gynecologic surgery: a randomized clinical trial
Q34428788Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis.
Q68016405Benefits and risks of unfractionated heparin in general surgery
Q37896527Bleeding and thromboembolic outcomes for patients on oral anticoagulation undergoing elective colon and rectal abdominal operations
Q44417557Bleeding peptic ulcer occurring in hospitalized patients: analysis of predictive and risk factors and comparison with out-of-hospital onset of hemorrhage
Q77325989Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism?
Q67541320Can the hierarchy in techniques for the prevention of thromboembolism in visceral surgery be determined?
Q53177363Catastrophic pulmonary and paradoxical embolism.
Q70790802Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet
Q28193059Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand
Q33392773Choosing the Right Heparin Prophylaxis Strategy in Medical Patients at Risk for Developing VTE: An Evidence-Based Approach
Q41115235Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials
Q37608455Clinical efficacy and safety of fondaparinux in the prevention and treatment of venous and arterial thrombosis
Q35159132Clinical experience of melagatran/ximelagatran in major orthopaedic surgery
Q47834411Clinical overview of venous thromboembolism
Q33384243Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement
Q37019860Clinical use of parnaparin in major and minor orthopedic surgery: a review
Q39169740Coagulation and fibrinolysis during lung surgery:an experimental study.
Q52330360Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure.
Q72114851Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration
Q86717254Comparative effectiveness in head and neck malignancies
Q36232265Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement.
Q91660927Complications of Retroperitoneal Lymph Node Dissection
Q34178716Complications of laparoscopy
Q48319318Complications of subcutaneous low-dose heparin therapy in neurosurgical patients
Q33495687Contemporary use of and future roles for heparin in antithrombotic therapy
Q33576223Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism
Q33543587Current concepts of coagulation and fibrinolysis
Q33492588Current trends in the development of anticoagulant and antithrombotic drugs.
Q28194897DVT prophylaxis and anticoagulation in the surgical patient
Q72726091DVT prophylaxis in total hip replacement
Q41139783Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders
Q37215274Deep Venous Thrombosis in the Surgical Intensive Care Unit
Q81584045Deep vein thrombosis
Q40582653Deep vein thrombosis of the lower limbs: diagnosis and management
Q41671908Deep vein thrombosis prophylaxis protocol--needs active enforcement
Q34144439Deep vein thrombosis: a clinical review
Q72158143Deep vein thrombosis: prevention in stroke patients during rehabilitation
Q77748222Deep venous thrombosis and pulmonary embolism in bilateral lower-extremity amputee patients
Q37503130Deep venous thrombosis and pulmonary embolism.
Q33650840Defining incidence and risk factors of venous thromboemolism after hepatectomy.
Q68166937Dermatan sulphate: A safe approach to prevention of postoperative deep vein thrombosis
Q36657982Development and validation of a predictive model for chemotherapy-associated thrombosis
Q35122966Diagnosis and treatment of pulmonary embolism in the elderly
Q34078303Diet as prophylaxis and treatment for venous thromboembolism?
Q37216645Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients
Q35594629Do anticoagulants improve survival in patients presenting with venous thromboembolism?
Q33415859Do postliver transplant patients need thromboprophylactic anticoagulation?
Q36156937Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty
Q94150613Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999
Q77137707Economic evaluation of the use of nadroparin calcium in the prophylaxis of deep vein thrombosis and pulmonary embolism in surgical patients in Italy
Q34552291Effect of inpatient quality of care on functional outcomes in patients with hip fracture
Q34560241Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials
Q43845104Effect of labor on maternal dehydration, starvation, coagulation, and fibrinolysis
Q73254160Effect of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty
Q35711442Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage
Q34343613Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
Q51106636Efficacy of deep venous thrombosis prophylaxis in the medical intensive care unit.
Q92276338Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
Q40541289Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease
Q37806818Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism
Q33501811Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology
Q34264218Epidemiology, risk factors and sequelae of venous thromboembolism
Q35739440Estimating anesthesia time using the medicare claim: a validation study
Q35101097Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux).
Q35570059Evidence‐based guidelines for fixing broken hips: an update
Q38605635Extended Pharmacologic Thromboprophylaxis in Oncologic Liver Surgery is Safe and Effective
Q34959822Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
Q33805098Extracts from "clinical evidence": hip fracture
Q26750983Failure to rescue patients from early critical complications of oesophagogastric cancer surgery
Q37210283Fatal pulmonary embolism in hospitalised medical patients
Q88801668Fibrin polymerization simulation using a reactive dissipative particle dynamics method
Q49167887Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison
Q34515387Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial
Q40868152Future research needs for venous thrombo-embolic disease in obstetrics and gynaecology
Q95799893Generalisations on benefits of aspirin are dangerous
Q77905389Global statement on deep venous thrombosis prophylaxis during laparoscopic surgery.SAGES position statement. Society of American Gastrointestinal Endoscopic Surgeons
Q35150857Glycosaminoglycans in Prophylaxis Against Venous Thromboembolism
Q34432531Graduated compression stockings in hip fractures
Q33719115Graduated compression stockings in the prevention of venous thromboembolism
Q50185648Hemodynamic, respiratory, and metabolic effects of laparoscopic cholecystectomy
Q47263066Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells
Q24194750Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
Q24239862Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)
Q24240104Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)
Q67567501Heparin in the treatment of deep venous thrombosis
Q43713377Heparin, deep venous thrombosis, and trauma patients
Q38264844Heparin-based treatment to prevent symptomatic deep venous thrombosis, pulmonary embolism or death in general medical inpatients is not supported by best evidence
Q24247417Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
Q58486041Hip fracture
Q71200405Hirudin CGP 39393 as thromboprophylaxis
Q50732455Identification of DVT diseases using numerical simulations.
Q37877058Identification of patient venous thromboembolism risk across the continuum of care
Q51068566Incidence of postoperative deep vein thrombosis after robotic-assisted laparoscopic prostatectomy: a prospective study in Chinese patients.
Q51555062Incidence of pulmonary thromboembolism in gastric cancer surgery using routine thromboprophylaxis.
Q68016390Incidence of thromboembolism depending on the type of surgery
Q38212499Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database.
Q80079335Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients
Q73979679Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Q42977224Interferon as treatment for acute hepatitis C. A meta-analysis
Q36821233Investigation of suspected lower limb venous thrombosis
Q45329950Is development of postoperative venous thromboembolism related to thromboprophylaxis use? A case-control study in the Veterans Health Administration
Q38117180Is extended thromboprophylaxis necessary in elective colorectal cancer surgery?
Q92120681Is pharmacological anticoagulant prophylaxis necessary for adolescent idiopathic scoliosis surgery?
Q41597142Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?
Q98181513Is venous thromboembolism a preventable cause of death?
Q28318920Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis
Q41182598Laparoscopic complications in markedly obese urologic patients (a multi-institutional review)
Q67494547Low molecular weight heparin in general and gynecologic surgery
Q34534567Low molecular weight heparin in prevention of perioperative thrombosis
Q33499141Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations
Q35233595Low molecular weight heparins. An objective overview
Q40832171Low molecular weight heparins: current use and indications
Q33569506Low molecular weight versus unfractionated heparin. A clinical and economic appraisal
Q47292625Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty
Q33332833Low-molecular-weight heparin for thrombophilia in pregnant women
Q77919968Low-molecular-weight heparins
Q42804922Massive pulmonary embolus in a 14 year old boy.
Q40238877Mechanical and pharmacological methods to prevent venous thromboembolism
Q45152223Medical complications in total laryngectomy: incidence and risk factors
Q47206731Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
Q34423980Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery
Q68349525Modern treatment of pulmonary embolism
Q34485192Monitoring for suspected pulmonary embolism.
Q35080331Monitoring of low molecular weight heparin in pregnancy
Q100940709Mortality benefits of thromboprophylaxis
Q100940711Mortality benefits of thromboprophylaxis - Authors' reply
Q34346122Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. The Venous Thromboembolism Study Group of the Spanish Society of Clinical Pharmacology
Q54509886Nationwide practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomy.
Q90743518Necessity of the Periodical Ultrasound Assessment of the Peripheral Venous System in Intensive Care Unit Patients
Q47338881New Therapeutic Opportunities for Heparins: What Does Low Molecular Weight Heparin Offer?
Q41593809New frontiers in the management of unstable coronary artery disease
Q34072627New therapeutic options in deep vein thrombosis prophylaxis.
Q34893606Oral heparin: status review
Q47097136Orthopaedic surgeons and thromboprophylaxis.
Q47126033Orthopaedic surgeons and thromboprophylaxis.
Q55419744Orthopaedic surgeons and thromboprophylaxis.
Q38095148Overview and assessment of risk factors for pulmonary embolism
Q43051829PREOP: development of an evidence-based expert system to assist with preoperative assessments
Q33487898Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders
Q34264223Pathways for venous thromboembolic prophylaxis in medical and surgical patients
Q70504771Peri-operative heparin: a possible adjuvant to surgery in colo-rectal cancer?
Q34283927Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery
Q38573932Perioperative Management of Antithrombotic Therapy in Common Otolaryngologic Surgical Procedures: State of the Art Review
Q40916978Perioperative care of the elderly patient
Q48426976Perioperative deep vein thrombosis in Chinese patients undergoing craniotomy
Q46630338Perioperative management of patients on oral anticoagulants: a decision analysis
Q34211162Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery
Q38611801Perioperative risk assessment. Common misconceptions
Q38915679Perioperative risk factors for death among patients with symptomatic pulmonary thromboembolism
Q31127779Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data
Q37568164Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins
Q34474103Physical examination findings in deep venous thrombosis
Q71968632Physical prevention of thrombosis with the ankle joint with the motorized ankle joint movement device. Initial results of a clinical study
Q40627711Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients
Q64967555Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy--an observational study.
Q50531670Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks?
Q63753999Postoperative fatal pulmonary embolism in a general surgical department
Q44017888Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison
Q36307908Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery
Q40594545Postsurgical complications in older patients. The role of pharmacological intervention.
Q33678527Practice parameters for the management of colonic cancer I: surgical issues. Recommendations of the Colorectal Surgical Society of Australia.
Q73681279Practices in the Prevention of Venous Thromboembolism
Q37669093Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients
Q44071706Predictors of mortality after acute hip fracture
Q39471557Prevalence of venous thromboembolism risk factors and prophylactic adequacy among general surgical patients in a tertiary care hospital
Q37681486Prevention and treatment of thromboembolic events in medical patients and new anticoagulants
Q33496843Prevention and treatment of venous thromboembolism
Q24632902Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Q24632872Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Q33370626Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin
Q67844218Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group
Q45016452Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.
Q37165360Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative study
Q40639985Prevention of postoperative venous thromboembolism following laparoscopic cholecystectomy
Q40641987Prevention of postoperative venous thromboembolism: an update
Q57943255Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
Q67541323Prevention of thromboembolism in gynecology
Q73433630Prevention of venous thromboembolism
Q35229348Prevention of venous thromboembolism after surgery: A review of enoxaparin
Q33359976Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors
Q44606092Prevention of venous thromboembolism in North America: results of a survey among general surgeons.
Q35513368Prevention of venous thromboembolism in Wales: results of a survey among general surgeons
Q35031645Prevention of venous thromboembolism in acute medical illness
Q33636726Prevention of venous thromboembolism in general surgery
Q39021399Prevention of venous thromboembolism in gynecologic oncology surgery
Q37393398Prevention of venous thromboembolism in hospitalized patients with cancer
Q53371904Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline.
Q35581095Prevention of venous thromboembolism in spinal surgery
Q71551072Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies)
Q58861106Prevenção do tromboembolismo na cirurgia do câncer do aparelho digestivo
Q37316796Primary prevention of venous thromboembolism in elderly medical patients
Q24187077Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
Q24203816Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
Q36822755Primary total hip replacement: variations in patient management in Oxford & Anglia, Trent, Yorkshire & Northern 'regions'.
Q34059375Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism
Q33919309Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis
Q51628283Prophylactic vena cava filter insertion in patients with traumatic spinal cord injury: preliminary results.
Q37944582Prophylaxis for deep vein thrombosis and pulmonary embolism in the geriatric patient undergoing surgery.
Q37939894Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient.
Q35537469Prophylaxis in elective colorectal surgery: the cost of ignoring the evidence
Q48887406Prophylaxis of Venous Thrombosis
Q74729697Prophylaxis of deep venous thrombosis and pulmonary embolism. Current recommendations
Q37827836Prophylaxis of venous thromboembolism
Q40522514Prophylaxis of venous thromboembolism in brain tumor patients
Q47366990Prospective randomized clinical study in general surgery comparing a new low molecular weight heparin with unfractionated heparin in the prevention of thrombosis
Q36821253Protocol violation in deep vein thrombosis prophylaxis
Q79954098Pulmonary embolism
Q67554800Pulmonary embolism in surgical practice
Q34196135Pulmonary embolism in the elderly
Q68004018Pulmonary embolism in the elderly
Q33334475Pulmonary embolus after coronary artery bypass surgery: a review of the literature.
Q71628839Pulmonary scintigraphy at the bedside in intensive care patients with suspected pulmonary embolism
Q54297862Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan.
Q54118938Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.
Q33348161Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy
Q77306749Rational antithrombotic therapy and prophylaxis in elderly, immobile patients
Q37180937Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis
Q80646999Re: Venous thromboembolism prophylaxis: is two better than one?
Q57313187Recent advances in cerebrovascular disease
Q36080543Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis
Q44261964Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the U
Q39877727Risk factors and prophylaxis for venous thromboembolism in hospitals in the city of Manaus, Brazil
Q50944058Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis.
Q35747987Risk factors for inpatient venous thromboembolism despite thromboprophylaxis
Q47760186Risk of Venous Thromboembolism Among Otolaryngology Patients vs General Surgery and Plastic Surgery Patients
Q67479995Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group
Q36120976Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients
Q77742224Risk reduction in the intensive care unit
Q28212759Risk-based evaluation of thromboprophylaxis among surgical inpatients: are low risk patients treated unnecessarily?
Q28316082Risk-benefit assessment of anticoagulant therapy
Q51446008Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
Q72614020Safety of preoperative enoxaparin in head and neck cancer surgery
Q52251926Screening for asymptomatic deep vein thrombosis in surgical intensive care patients.
Q50775335Seasonal variation in occurrence of pulmonary embolism: analysis of the database of the Emilia-Romagna region, Italy.
Q35160253Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery
Q33394876Side-effects of antithrombotic therapy
Q36790943Some limits to evidence-based medicine: a case study from elective orthopaedics
Q39004019Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty
Q38053889Statins for the prevention of venous thromboembolism? a narrative review
Q59075880Statistics of chronic disease control
Q37961826Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies
Q45922621Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis.
Q28354097Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial
Q41121444Surgical debate. We still have insufficient evidence to support perioperative heparin prophylaxis against venous thromboembolism
Q34989818Surgical treatment of colon and rectal cancer.
Q35056481Survey of pharmacologic thromboprophylaxis in critically ill children
Q28088683Systematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis
Q37232098The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force
Q97542590The Pathway to Low Outlier Status in Venous Thromboembolism Events: An Analysis of Pancreatic Surgery in the National Surgical Quality Improvement Program
Q40543054The Prevention of Venous Thromboembolism in Surgical Patients
Q42560177The aspirin papers
Q47349893The defined daily doses of low molecular weight heparins do not reflect current clinical practice
Q33698200The effect of a continuing medical education program on Venous thromboembolism prophylaxis utilization and mortality in a tertiary-care hospital
Q54593707The effect of new oral anticoagulants and extended thromboprophylaxis policy on hip and knee arthroplasty outcomes: observational study.
Q41938437The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty
Q37179099The impact of inherited thrombophilia on surgery: a factor to consider before transplantation?
Q38568574The natural history and epidemiology of venous thrombosis
Q40487628The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement
Q40752692The pathophysiology of venous thrombosis
Q35656148The pulmonary physician and critical care. 5. Management of pulmonary embolism
Q41355836The risk of thromboembolism in patients undergoing colorectal surgery.
Q36259760The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests
Q37117062The use of antiembolic stockings. Part 1: a literature review
Q67976890The use of thromboprophylaxis in total hip replacement surgery: are the attitudes of orthopaedic surgeons changing?
Q34648639Therapeutic equivalency of low-molecular-weight heparins
Q44868404Thrombin-Responsive Transcutaneous Patch for Auto-Anticoagulant Regulation
Q55484259Thromboembolic phenomena in neurosurgical patients operated upon for primary and metastatic brain tumours
Q26825670Thromboembolism prevention in surgery of digestive cancer
Q37213750Thromboembolism prophylaxis. Choosing the proper method for surgical patients
Q40912552Thrombolysis for life-threatening pulmonary embolism 2 days after lung resection
Q35081863Thromboprophylaxis and thrombosis in medical, surgical, trauma, and obstetric/gynecologic patients
Q42785688Thromboprophylaxis for adults in hospital
Q33915936Thrombosis risk in the trauma patient. Prevention and treatment
Q42281396Thrombotic risk assessment questionary helps increase the use of thromboprophylaxis for patients with pelvic and acetabular fractures
Q50530432Timing of preoperative pharmacoprophylaxis for pancreatic surgery patients: a venous thromboembolism reduction initiative.
Q73052586Tolerability, pharmacokinetics, and pharmacodynamics of DX-9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers
Q36937149Tonsillectomy in the anticoagulated patient
Q38730070Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children
Q34047349Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis.
Q46210022Trials of antiplatelet therapy: Authors' reply
Q41355828Unresolved issues in the prevention of venous thromboembolism.
Q40880210Update. Deep vein thrombosis and pulmonary embolism prophylaxis in orthopedic surgery.
Q36821944Use of a thromboembolic risk score to improve thromboprophylaxis in surgical patients
Q24802144Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study
Q34791576Usefulness of the computed tomography venography for evaluation of leg edema including deep vein thrombosis in rehabilitation patients
Q53430758Variation in Hospital Thromboprophylaxis Practices for Abdominal Cancer Surgery.
Q43154529Variation in physician deep vein thrombosis prophylaxis attitudes and practices at an academic tertiary care center
Q33970367Vascular drugs in the new millennium
Q57211198Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial
Q38613357Venous Thromboembolism Prophylaxis in Liver Surgery
Q40559027Venous Thromboembolism Prophylaxis in a South Australian Teaching Hospital
Q35815447Venous Thromboembolism-Incidence of Deep Venous Thrombosis and Pulmonary Embolism in Patients with Head and Neck Cancer: A Tertiary Care Experience in Pakistan
Q71574398Venous hemodynamics during impulse foot pumping
Q40836864Venous thromboembolic complications in children
Q33935332Venous thromboembolic complications in obstetrics and gynecology with a focus on the role of low molecular weight heparin
Q37427823Venous thromboembolic disease in colorectal patients
Q55214497Venous thromboembolic disease in uncemented total hip replacement surgery--a one-year follow-up of 490 patients.
Q33415676Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons
Q77712999Venous thromboembolic prophylaxis for transurethral prostatectomy: practice among British urologists
Q41256710Venous thromboembolism (VTE) prophylaxis and urological pelvic cancer surgery: a UK national audit
Q36330566Venous thromboembolism (VTE) risk assessment and prophylaxis in acute orthopaedic admissions: improving compliance with national guidelines
Q48559598Venous thromboembolism after hepatic resection: analysis of 5,706 patients
Q45034330Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations.
Q37566749Venous thromboembolism after oral and maxillofacial oncologic surgery: Report and analysis of 14 cases in Chinese population.
Q33906746Venous thromboembolism after surgery for benign prostatic hyperplasia
Q34342941Venous thromboembolism and cancer: prevention of VTE.
Q44355973Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study
Q90399293Venous thromboembolism in head and neck surgery: Risk, outcome, and burden at the national level
Q37137952Venous thromboembolism in hospitalised patients: a public health crisis?
Q35103066Venous thromboembolism in intensive care patients
Q38117302Venous thromboembolism in otolaryngology surgical inpatients receiving chemoprophylaxis
Q26797444Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis
Q33673802Venous thromboembolism in the intensive care unit
Q73280080Venous thromboembolism in the intensive care unit
Q40617575Venous thromboembolism in trauma patients
Q84974214Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment
Q36797819Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review
Q39457080Venous thromboembolism prophylaxis in urology: A review
Q89684331Venous thromboembolism rates after hip and knee arthroplasty and hip fractures
Q37197643Venous thromboembolism: A problem in the Indian/Asian population?
Q81829757Venous thromboembolism: an ounce of prevention
Q34351113Venous thrombosis and anticoagulant therapy
Q40559351Venous thrombosis: prevention, treatment, and relationship to paradoxical embolization.
Q64966305What has changed in venous thromboembolism prophylaxis for hospitalized patients over recent decades: review article.
Q54975780Why Do Patients Bleed?
Q67567473Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?
Q44217663Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial
Q80175242[An update on thrombosis prophylaxis in orthopaedic and accident surgery]
Q79968288[Antithrombotic drugs in urological surgery. Treatment interfering with haemostasis in urology?]
Q73278001[Aspirin and venous thromboembolism: some indications, but no certitude]
Q68016402[Benefits and risks of unfractionated heparin in orthopedic surgery]
Q81323802[Factors affecting quality of care for elderly subjects undergoing surgery for hip fracture: review of the literature]
Q79538402[Perioperative hemostasis management]
Q73564383[Preventing and treating venous thrombosis in 1997]
Q84201604[Prevention of venous thromboembolic disease in general surgery]
Q73230110[Treatment of submasive pulmonary embolism with low-molecular-weight heparin]
Q83743922[Update in pulmonary thromboembolic disease]
Q82993855[Venous thromboembolic disease in general surgery]

Search more.